China Shineway Pharmaceutical Group Limited (2877.HK)
HKD 9.43
(-1.26%)
HKD 9.43
(-1.26%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 4.51 Billion | 3.95 Billion | 3.22 Billion | 2.65 Billion | 2.7 Billion | 2.57 Billion |
| Cost of Revenue | 1.12 Billion | 1.01 Billion | 813.21 Million | 667.85 Million | 724.43 Million | 694.14 Million |
| Gross Profit | 3.39 Billion | 2.93 Billion | 2.41 Billion | 1.98 Billion | 1.98 Billion | 1.87 Billion |
| Operating Expenses | 2.41 Billion | 2.11 Billion | 1.79 Billion | 1.7 Billion | 1.45 Billion | 1.34 Billion |
| Selling, General and Administrative Expenses | 2.3 Billion | 2.1 Billion | 1.76 Billion | 1.46 Billion | 1.4 Billion | 1.25 Billion |
| Research and Development Expenses | 110.46 Million | 117.45 Million | 112.71 Million | 99.7 Million | 102.71 Million | 128.12 Million |
| Other Expenses | - | 104.98 Million | 82.85 Million | 86.16 Million | 86.14 Million | 38.77 Million |
| Cost and Expenses | 3.54 Billion | 3.13 Billion | 2.6 Billion | 2.37 Billion | 2.18 Billion | 2.03 Billion |
| Operating Income | 975.53 Million | 713.57 Million | 534.36 Million | 422.39 Million | 476.48 Million | 494.29 Million |
| Interest Expense | 2.73 Million | 630 Thousand | 1.25 Million | 16.6 Million | 2.65 Million | - |
| Income Tax Expense | 270.74 Million | 194.25 Million | 163.42 Million | 99.99 Million | 139.62 Million | 163.25 Million |
| Earnings before Tax | 1.24 Billion | 917.02 Million | 720.1 Million | 395.02 Million | 642.77 Million | 669.13 Million |
| Net Income | 969.51 Million | 722.77 Million | 556.67 Million | 295.03 Million | 503.15 Million | 505.87 Million |
| Earnings Per Share Basic | 1.28 | 0.96 | 0.74 | 0.39 | 0.64 | 0.62 |
| Earnings Per Share Diluted | 1.28 | 0.96 | 0.74 | 0.39 | 0.64 | 0.62 |
| Weighted Average Shares Outstanding | 755.4 Million | 755.4 Million | 755.14 Million | 756.49 Million | 780.81 Million | 816.38 Million |
| Weighted Average Shares Outstanding (Diluted) | 755.4 Million | 755.4 Million | 755.14 Million | 756.74 Million | 780.94 Million | 817.86 Million |
| Gross Margin | 0.75 | 0.74 | 0.75 | 0.75 | 0.73 | 0.73 |
| EBIT Margin | 0.31 | 0.22 | 0.22 | 0.23 | 0.25 | 0.27 |
| Profit Margin | 0.21 | 0.18 | 0.17 | 0.11 | 0.19 | 0.20 |
| EBITDA | 1.42 Billion | 1.1 Billion | 903.74 Million | 620.03 Million | 672.7 Million | 691.76 Million |
| Earnings Before Tax Margin | 0.22 | 0.18 | 0.17 | 0.16 | 0.18 | 0.19 |
| Breakdown | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 FY | 2022 Q4 | 2022 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 2.11 Billion | 4.51 Billion | 2.39 Billion | 3.95 Billion | 2.13 Billion | 1.81 Billion |
| Cost of Revenue | 527.69 Million | 1.12 Billion | 594.72 Million | 1.01 Billion | 521.94 Million | 490.38 Million |
| Gross Profit | 1.59 Billion | 3.39 Billion | 1.8 Billion | 2.93 Billion | 1.61 Billion | 1.32 Billion |
| Operating Expenses | 1.06 Billion | 2.41 Billion | 1.18 Billion | 2.11 Billion | 1.15 Billion | 969.58 Million |
| Selling, General and Administrative Expenses | 1.14 Billion | - | 1.16 Billion | - | 1.15 Billion | 954.2 Million |
| Research and Development Expenses | 62.26 Million | - | 48.19 Million | - | 88.78 Million | 28.67 Million |
| Other Expenses | - | 167.38 Million | - | 104.98 Million | - | - |
| Cost and Expenses | 1.59 Billion | 3.54 Billion | 1.78 Billion | 3.13 Billion | 1.67 Billion | 1.45 Billion |
| Operating Income | 384.09 Million | 970.09 Million | 586 Million | 713.57 Million | 371.64 Million | 341.93 Million |
| Interest Expense | - | 2.73 Million | - | 630 Thousand | - | - |
| Income Tax Expense | 90.92 Million | 270.74 Million | 179.82 Million | 194.25 Million | 113.96 Million | 80.28 Million |
| Earnings before Tax | 568.96 Million | 1.24 Billion | 671.28 Million | 917.02 Million | 505.61 Million | 411.4 Million |
| Net Income | 478.04 Million | 969.51 Million | 491.46 Million | 722.77 Million | 391.65 Million | 331.12 Million |
| Earnings Per Share Basic | 0.63 | - | 0.65 | - | 0.52 | 0.44 |
| Earnings Per Share Diluted | 0.63 | - | 0.65 | - | 0.52 | 0.44 |
| Weighted Average Shares Outstanding | 758.8 Million | 755.4 Million | 756.1 Million | 755.4 Million | 755.4 Million | 755.4 Million |
| Weighted Average Shares Outstanding (Diluted) | 755.4 Million | 755.4 Million | 755.4 Million | 755.4 Million | 755.4 Million | 755.4 Million |
| Gross Margin | 0.75 | 0.75 | 0.75 | 0.74 | 0.76 | 0.73 |
| EBIT Margin | 0.22 | - | 0.28 | - | 0.21 | 0.24 |
| Profit Margin | 0.23 | 0.21 | 0.20 | 0.18 | 0.18 | 0.18 |
| EBITDA | 463.87 Million | - | 672.1 Million | - | 452.42 Million | 435.8 Million |
| Earnings Before Tax Margin | 0.18 | 0.21 | 0.24 | 0.18 | 0.17 | 0.19 |
AAVMY
0IJN
TU
WTB
IDEX
2708